Literature DB >> 17667630

Candida albicans interface infection after deep anterior lamellar keratoplasty.

Luigi Fontana1, Gabriella Parente, Bruna Di Pede, Giorgio Tassinari.   

Abstract

PURPOSE: To report a case of interface infection by Candida albicans after deep anterior lamellar keratoplasty (DALK).
METHODS: A 30-year-old man with keratoconus underwent DALK. Four weeks after surgery, the patient developed multiple infiltrates in the graft-host interface with absence of intraocular infection. Donor rim cultures grew C. albicans. Penetrating keratoplasty (PK) was performed because of worsening of the infection despite topical, local, and systemic antifungal therapy.
RESULTS: Cultures carried out on the excised donor cornea confirmed donor-to-host transmission of C. albicans. An aqueous tap taken before PK was negative. Six months after PK, the corneal graft was clear with no recurrence of infection.
CONCLUSIONS: After DALK, in cases of donor graft microbial contamination, infection may develop at the graft-host interface. This may delay or prevent direct intraocular penetration of microorganisms, reducing the risk of development of endophthalmitis. PK may be needed to eradicate the infection in cases where conservative treatment fails.

Entities:  

Mesh:

Year:  2007        PMID: 17667630     DOI: 10.1097/ICO.0b013e318074e475

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  18 in total

1.  Acute Klebsiella pneumoniae interface keratitis after deep anterior lamellar keratoplasty.

Authors:  Siamak Zarei-Ghanavati; Mohammad-Reza Sedaghat; Ali Ghavami-Shahri
Journal:  Jpn J Ophthalmol       Date:  2011-02-18       Impact factor: 2.447

2.  Candida interface keratitis following deep anterior lamellar keratoplasty.

Authors:  Ayse E Bahadir; Tahir K Bozkurt; Selda Aktay Kutan; Cemil A Yanyali; Suphi Acar
Journal:  Int Ophthalmol       Date:  2012-03-27       Impact factor: 2.031

3.  Incidence and Outcomes of Positive Donor Rim Cultures and Infections in the Cornea Preservation Time Study.

Authors:  Shahzad I Mian; Anthony J Aldave; Elmer Y Tu; Brandon D Ayres; Bennie H Jeng; Marian S Macsai; Michael L Nordlund; Jeffrey G Penta; Sudeep Pramanik; Loretta B Szczotka-Flynn; Allison R Ayala; Wendi Liang; Maureen G Maguire; Jonathan H Lass
Journal:  Cornea       Date:  2018-09       Impact factor: 2.651

4.  Current Concepts in the Management of Unique Post-keratoplasty Infections.

Authors:  Julie M Schallhorn; Jennifer Rose-Nussbaumer
Journal:  Curr Ophthalmol Rep       Date:  2015-06-12

5.  Fungal interface keratitis by Candida orthopsilosis following deep anterior lamellar keratoplasty.

Authors:  Julia M Wessel; Björn O Bachmann; Ralph Meiller; Friedrich E Kruse
Journal:  BMJ Case Rep       Date:  2013-01-23

Review 6.  Post-keratoplasty Infectious Keratitis: Epidemiology, Risk Factors, Management, and Outcomes.

Authors:  Anna Song; Rashmi Deshmukh; Haotian Lin; Marcus Ang; Jodhbir S Mehta; James Chodosh; Dalia G Said; Harminder S Dua; Darren S J Ting
Journal:  Front Med (Lausanne)       Date:  2021-07-07

7.  Candida albicans interface infection after deep anterior lamellar keratoplasty.

Authors:  Mohammad Reza Sedaghat; Setareh Sagheb Hosseinpoor
Journal:  Indian J Ophthalmol       Date:  2012-07       Impact factor: 1.848

8.  Aspergillus keratitis after deep anterior lamellar keratoplasty.

Authors:  Afshin Lotfi Sadigh; Abdollah Shenasi; Seyed Ziaeddin Mortazavi; Seyed Mohammad Morsali
Journal:  J Ophthalmic Vis Res       Date:  2014 Jul-Sep

9.  Interface infectious keratitis following deep anterior lamellar keratoplasty.

Authors:  Shreesha Kumar Kodavoor; Ramamurthy Dandapani; Ajay Ramesh Kaushik
Journal:  Indian J Ophthalmol       Date:  2016-08       Impact factor: 1.848

Review 10.  Interface infectious keratitis after anterior and posterior lamellar keratoplasty. Clinical features and treatment strategies. A review.

Authors:  Luigi Fontana; Antonio Moramarco; Erika Mandarà; Giuseppe Russello; Alfonso Iovieno
Journal:  Br J Ophthalmol       Date:  2018-10-24       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.